CLINICAL_TRIALS
trial_result
· 2025-01-07
Clinical Trial Update: Scleroderma Treatment With Autologous Transplant (STAT) Study [Phase 2]
Summary
Phase 2 trial results update for autologous hematopoietic stem cell transplantation in systemic sclerosis (STAT) study; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Systemic Scleroderma | Phase 2 | Status: COMPLETED | Results posted: 2025-01-07